DUSA Pharma Levulan Kerastick receives marketing approval in Korea

Co announces that the Korea Food and Drug Administration has approved Levulan Kerastick for Photodynamic Therapy for the treatment of actinic keratoses through its marketing partner Daewoong Pharmaceutical and its affiliate, DNC Daewoong Derma & Plastic Surgery Network. Having received approval, market launch is expected in the first quarter of 2008.